{"product_id":"mirion-swot-analysis","title":"Mirion SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete SWOT Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMirion’s strengths in radiation detection tech and diversified end-markets position it well for steady growth, but supply-chain risks and regulatory complexity could weigh on margins; our full SWOT unpacks these dynamics with revenue drivers, competitor comparison, and mitigation strategies. Purchase the complete SWOT analysis to receive a professionally formatted Word report and editable Excel matrix—ready to inform investment, strategy, or M\u0026amp;A decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRecord Order Backlog and Market Demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpmirion closed with a record order backlog above billion up sharply from roughly million in driven mainly by nuclear power safety and instrumentation contracts.\u003e\n\u003cpthis surge gives clear revenue visibility into with backlog covering an estimated of projected based on guidance.\u003e\n\u003cpsuch demand underscores mirion market leadership and the high trust global utilities place in its specialized safety-critical offerings.\u003e\n\u003c\/psuch\u003e\u003c\/pthis\u003e\u003c\/pmirion\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified Revenue and Installed Base\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMirion’s business is highly resilient: about 80% of FY2024 revenue came from its installed base, driven by upgrades, maintenance, and life‑extension work that generate steady recurring cash regardless of new builds.\u003c\/p\u003e\n\u003cp\u003eSales spread across nuclear, medical, and defense reduces concentration risk; for example, nuclear services were ~38% of 2024 revenue, medical ~34%, defense ~28%, helping sustain growth during sector slowdowns.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Acquisitions and Portfolio Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Paragon Energy Solutions (acquired 2023) and Certrec (2024) integrations strengthened Mirion’s North American nuclear capabilities, adding regulatory SaaS and critical hardware across reactor lifecycles.\u003c\/p\u003e\n\u003cp\u003eThese deals raised nuclear-related revenue to ~48% of Mirion’s total by FY2025, with combined pro forma revenue growth of ~15% and targeted synergies driving margin expansion toward management’s 2026 targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImproved Capital Structure and Liquidity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMirion refinanced debt in 2025, cutting its average borrowing cost from \u0026gt;7% to \u0026lt;3% via term loan reductions and low-coupon convertible notes, driving substantial interest savings.\u003c\/p\u003e\n\u003cp\u003eThose savings doubled adjusted free cash flow year-over-year, and cash on hand exceeded $400 million, funding R\u0026amp;D and strategic M\u0026amp;A capacity.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCost of debt: \u0026gt;7% → \u0026lt;3%\u003c\/li\u003e\n\u003cli\u003eDoubled adjusted FCF (YoY)\u003c\/li\u003e\n\u003cli\u003eCash: \u0026gt;$400M available\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Leadership and Regulatory Moat\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMirion’s deep IP and adherence to IEC and NRC standards create a regulatory moat; the firm held ~350 global patents and reported 2024 revenue of $760m, with 65% recurring from service and calibration contracts.\u003c\/p\u003e\n\u003cp\u003eRadiation detection and QA demand specialist expertise, raising entry costs and protecting margins; products embedded in hospitals and nuclear plants yield \u0026gt;90% retention and allow premium pricing.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~350 patents\u003c\/li\u003e\n\u003cli\u003e$760m 2024 revenue\u003c\/li\u003e\n\u003cli\u003e65% recurring\u003c\/li\u003e\n\u003cli\u003e\u0026gt;90% customer retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMirion: $1B+ backlog, $400M+ cash, 65% recurring revenue—strong cashflow \u0026amp; growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMirion’s strengths: \u0026gt;$1.0B 2025 backlog (vs ~$680M 2023) covering ~60–75% of 2026 revenue; 2024 revenue $760M with ~65% recurring; ~350 patents; \u0026gt;90% customer retention; nuclear revenue ~48% FY2025 after Paragon\/Certrec deals; debt cost cut \u0026gt;7%→\u0026lt;3%, cash \u0026gt;$400M, adjusted FCF doubled YoY.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2025 backlog\u003c\/td\u003e\n\u003ctd\u003e$1.0B+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$760M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e~350\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash\u003c\/td\u003e\n\u003ctd\u003e$400M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clear SWOT framework for analyzing Mirion’s business strategy, highlighting its core strengths, operational weaknesses, market opportunities, and external threats shaping future performance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise Mirion SWOT snapshot for rapid strategic alignment and stakeholder-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuarterly Earnings and Revenue Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite 18% FY2025 revenue growth to $950m, Mirion missed analyst Q4 2025 estimates—EPS $0.42 vs. $0.55 consensus and revenue $230m vs. $245m—highlighting timing risk in large projects and government orders.\u003c\/p\u003e\n\u003cp\u003eSuch swings fuel short-term stock volatility (shares fell ~9% on the print) and raise investor concern about quarterly consistency.\u003c\/p\u003e\n\u003cp\u003eAs Mirion shifts toward bigger contracts, managing market expectations and smoothing guidance will be critical to avoid recurring price shocks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMargin Dilution from New Acquisitions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAcquisitions like Paragon expanded Mirion’s reach but caused initial margin dilution, cutting adjusted EBITDA margin by roughly 120–180 basis points in 2024 vs. pro forma 2023 as integration and purchase accounting hit results.\u003c\/p\u003e\n\u003cp\u003eBringing Paragon onto Mirion’s platform needs heavy ops work and procurement savings; management targets restoring margins within 12–24 months once €10–15m annualized synergies are captured.\u003c\/p\u003e\n\u003cp\u003eShort-term integration costs and working-capital moves keep consolidated adjusted EBITDA depressed, and investors watch KPIs—synergy run-rate, gross margin recovery, and integration spend—for signs of friction or delays.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWeakness in Medical Hardware Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe medical segment saw organic revenue declines in 2025 in regions including Japan, driven by weak radiation therapy quality-assurance hardware sales and a tougher US healthcare capital-spend environment; medical revenue fell about 6% year-over-year in H1 2025 versus flat growth in the nuclear segment. Hospitals’ budget cycles made the division more sensitive to capex pullbacks, with US hospital capital expenditure down ~4% in 2024–25, pressuring order books. Addressing this sluggishness is critical to sustain Mirion’s overall growth and hit the 2025 guidance of low-double-digit adjusted EBITDA expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Relative Valuation Metrics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmirion often trades at a p around versus peer median consensus pricing in strong growth any organic slowdown could trigger sharp re-rating.\u003e\n\u003cpthe company financials include multiple non-gaap adjustments and convertible instruments complicating valuation for retail investors increasing sensitivity to forecast errors.\u003e\n\u003cpmaintaining\u003e15% revenue growth is needed to justify current multiples; missed quarters would likely prompt large share-price moves.\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eP\/E ~45x vs peer 22x (2025)\u003c\/li\u003e\n\u003cli\u003eRequires \u0026gt;15% revenue growth to justify premium\u003c\/li\u003e\n\u003cli\u003eComplex non-GAAP items and convertibles hinder clear valuation\u003c\/li\u003e\n\u003cli\u003eLittle margin for error—downgrade risk on slower organic growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmaintaining\u003e\u003c\/pthe\u003e\u003c\/pmirion\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComplexity of Global Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOperating in 100+ countries exposes Mirion Technologies plc to heavy logistical and admin complexity; in 2024 overseas revenue made up about 78% of total sales, so supply-chain hiccups can hit revenue quickly.\u003c\/p\u003e\n\u003cp\u003ePost-2021 acquisition growth left diverse product lines and cultures to harmonize; integration costs ran ~3–4% of revenue in recent years and remain a management drain.\u003c\/p\u003e\n\u003cp\u003eLocalized regulatory shifts or supply delays have shifted production timelines by weeks, raising unit costs; unifying digital\/ops platforms is a multi-year, resource-intensive program.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e78% revenue from international markets (2024)\u003c\/li\u003e\n\u003cli\u003eIntegration costs ~3–4% of revenue\u003c\/li\u003e\n\u003cli\u003e100+ country footprint\u003c\/li\u003e\n\u003cli\u003eMulti-year global platform rollout\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGrowth miss, margin hit and pricey valuation: Paragon deal raises timing \u0026amp; integration risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh growth missed Q4 EPS $0.42 vs $0.55 and rev $230m vs $245m, causing ~9% share drop; reliance on large gov\/contracts raises timing risk. Paragon acquisition cut adj. EBITDA margin ~120–180 bps; integration costs ~3–4% of revenue with €10–15m target synergies (12–24 months). Medical sales fell ~6% H1 2025; 78% revenue international exposure. P\/E ~45x vs peer 22x (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 Revenue\u003c\/td\u003e\n\u003ctd\u003e$950m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ4 2025 EPS\u003c\/td\u003e\n\u003ctd\u003e$0.42 (cons $0.55)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdj. EBITDA margin hit\u003c\/td\u003e\n\u003ctd\u003e-120–180 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntegration cost\u003c\/td\u003e\n\u003ctd\u003e3–4% of revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical H1 2025 change\u003c\/td\u003e\n\u003ctd\u003e-6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e78%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eP\/E (2025)\u003c\/td\u003e\n\u003ctd\u003e~45x vs peer 22x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eMirion SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Mirion SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full report you'll get; buy to unlock the complete, editable version. You’re viewing a live excerpt of the real file, structured and ready to use immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752520200569,"sku":"mirion-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/mirion-swot-analysis.png?v=1772241949","url":"https:\/\/matrixbcg.com\/products\/mirion-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}